Amsterdam, The Netherlands - 15 August 2018
Esperite NV announces having solved the technical issues that caused the delay regarding the publication of the Annual Report 2017. The departments involved are now able to make significant progress to finalize the Annual Report 2017.
Due to the holliday season, Esperite is not able to indicate an accurate date for publication of the Annual Report 2017 and will give an update before the end of August 2018.
About ESPERITE
ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.
To learn more about the ESPERITE Group, or to book an interview with CEO Frédéric Amar: +31 575 548 998 - ir@esperite.com or visit the websites at www.esperite.com, www.genoma.com and www.cryo-save.com.
***
This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).
